Skip to content

Comparison of Two Spinal Needles Regarding Postdural Puncture Headache

Postdural Puncture Headache After Spinal Anesthesia for Cesarean Section, Two Different Needles.

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01821807
Enrollment
256
Registered
2013-04-01
Start date
2013-06-30
Completion date
2013-07-31
Last updated
2014-03-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anesthesia; Adverse Effect, Spinal and Epidural, Headache, Complications; Anesthesia, Spinal and Epidural, in Pregnancy

Keywords

spinal anesthesia, spinal needle, cesarean section, headache, backache

Brief summary

The aim of the study is to observe the rate of postdural puncture headache observed after spinal anesthesia in cesarean section patients. Two kind of spinal anesthesia needles will be used: 1. 26 Gauge Quincke (cutting-tip needle) 2. 26 Gauge Atraucan (atraumatic needle) The investigators will observe: 1. Number of spinal punctures 2. Time required for the spinal anesthesia procedure Patients will be evaluated after 7 days for: 1. Headache 2. Backache

Detailed description

It is a known phenomenon that spinal anesthesia sometimes results in headache. The aim of the study is to observe the rate of postdural puncture headache observed after spinal anesthesia in cesarean section patients. Two kind of spinal anesthesia needles will be used: 1. 26 Gauge Quincke (cutting-tip needle) 2. 26 Gauge Atraucan (atraumatic needle) We will observe: 1. Number of spinal punctures 2. Time required for the spinal anesthesia procedure Patients will be evaluated after 7 days for: 1. Headache 2. Backache 2 kind of spinal anesthesia needles will be used, but no comparison will be made. This is an observational study. Although literature gives different rates of postdural puncture headache for these two needles, we observe the same rate of headache in our clinical practice. We want to define the real rate of postdural puncture headache in patients undergoing cesarean section with spinal anesthesia.

Interventions

None listed

Sponsors

Adiyaman University Research Hospital
Lead SponsorOTHER

Study design

Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 40 Years
Healthy volunteers
No

Inclusion criteria

* Pregnant female patients between 18-40 years old undergoing cesarean section * Patient accepting spinal anesthesia

Exclusion criteria

* Infection at the spinal needle insertion cite * Coagulability disorder * Patient not accepting the procedure

Design outcomes

Primary

MeasureTime frameDescription
Postdural Puncture Headache in Patients Receiving Spinal Anesthesia for Cesarean Section1 weekPatients were observer for the symptoms of headache (PDPH) for 1 week. On the 1st postoperative day they were visited in the clinic. On the 7th postoperative day they were contacted by telephone and were asked about the symptoms.

Secondary

MeasureTime frameDescription
Backache in Patients Receiving Spinal Anesthesia for Cesarean Section1 weekPatients were observer for the symptoms of postdural puncture backache for 1 week. On the 1st postoperative day they were visited in the clinic. On the 7th postoperative day they were contacted by telephone and were asked about the symptoms.

Countries

Turkey (Türkiye)

Participant flow

Recruitment details

All the patients in the first month of study were selected in group Quincke. All the others recruited in the second month of the study were enrolled in group Atraucan.

Pre-assignment details

Non-compliance to the suggestions of the investigators for the part of patients and loss of the contact with the patient were criteria for exclusion.

Participants by arm

ArmCount
26 Gauge Quincke
Patients (n=150) will be treated with 26 gauge quincke spinal needle for spinal anesthesia for cesarean section.
150
26 Gauge Atraucan
Patients (n=110) will be treated with 26 gauge atraucan spinal needle for spinal anesthesia for cesarean section.
110
Total260

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyLost to Follow-up31

Baseline characteristics

Characteristic26 Gauge AtraucanTotal26 Gauge Quincke
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
0 Participants0 Participants0 Participants
Age, Categorical
Between 18 and 65 years
110 Participants260 Participants150 Participants
Age, Continuous29.2 years
STANDARD_DEVIATION 4.8
29.8 years
STANDARD_DEVIATION 5.2
30.2 years
STANDARD_DEVIATION 5.5
Region of Enrollment
Turkey
110 participants260 participants150 participants
Sex: Female, Male
Female
110 Participants260 Participants150 Participants
Sex: Female, Male
Male
0 Participants0 Participants0 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
1 / 1471 / 109
serious
Total, serious adverse events
79 / 14778 / 109

Outcome results

Primary

Postdural Puncture Headache in Patients Receiving Spinal Anesthesia for Cesarean Section

Patients were observer for the symptoms of headache (PDPH) for 1 week. On the 1st postoperative day they were visited in the clinic. On the 7th postoperative day they were contacted by telephone and were asked about the symptoms.

Time frame: 1 week

ArmMeasureValue (NUMBER)
26 Gauge QuinckePostdural Puncture Headache in Patients Receiving Spinal Anesthesia for Cesarean Section14 participants
26 Gauge AtraucanPostdural Puncture Headache in Patients Receiving Spinal Anesthesia for Cesarean Section10 participants
Secondary

Backache in Patients Receiving Spinal Anesthesia for Cesarean Section

Patients were observer for the symptoms of postdural puncture backache for 1 week. On the 1st postoperative day they were visited in the clinic. On the 7th postoperative day they were contacted by telephone and were asked about the symptoms.

Time frame: 1 week

ArmMeasureValue (NUMBER)
26 Gauge QuinckeBackache in Patients Receiving Spinal Anesthesia for Cesarean Section65 participants
26 Gauge AtraucanBackache in Patients Receiving Spinal Anesthesia for Cesarean Section68 participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026